BRAF V600 Mutation and BRAF Kinase Inhibitors in Conjunction With Stereotactic Radiosurgery for Intracranial Melanoma Metastases: A Multicenter Retrospective Study
Panagiotis Mastorakos(Thomas Jefferson University Hospital), Jason P. Sheehan(University of Virginia), Jack M. Qian(South Shore Hospital), Ronald E. Warnick(Mercy Health), Veronica Chiang(Yale University), James B. Yu(Harvard University), Zhiyuan Xu(Zhejiang Cancer Hospital), Ajay Chatrath(University of Virginia), Davis G. Taylor(University of Virginia Health System), Judith Hess(Yale University), Douglas Kondziolka(Neurological Surgery)
Cited by 37
Related Papers
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients
|International Journal of Radiation Oncology*Biology*Physics|2009|984
Estimating Survival in Patients With Lung Cancer and Brain Metastases
|JAMA Oncology|2016|655
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|Radiotherapy and Oncology|2020|646